Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study
Author(s) -
Sigrun Kjøtrød,
Sven M. Carlsen,
Per Emil Rasmussen,
T. Holst-Larsen,
Jan Roar Mellembakken,
Ann ThurinKjellberg,
K. HaapaniemiKouru,
Laure MorinPapunen,
Peter Humaidan,
A. Sunde,
Vidar von Dûring
Publication year - 2011
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/der154
Subject(s) - polycystic ovary , metformin , medicine , placebo , pregnancy , pregnancy rate , gynecology , live birth , body mass index , confidence interval , assisted reproductive technology , obstetrics , randomized controlled trial , prospective cohort study , infertility , obesity , insulin resistance , biology , insulin , alternative medicine , pathology , genetics
To study the effect of metformin before and during assisted reproductive technology (ART) on the clinical pregnancy rate (CPR) in non-obese women with polycystic ovary syndrome (PCOS).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom